Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
about
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtypeHuman epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.A genome-wide association study of prognosis in breast cancer.How many etiological subtypes of breast cancer: two, three, four, or more?Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.Effects of interval between age at first pregnancy and age at diagnosis on breast cancer survival according to menopausal status: a register-based study in KoreaExpression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study.Epidemiology of basal-like breast cancer.Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Breast cancer adjuvant therapy: time to consider its time-dependent effects.Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumGenetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.The role of the basal stem cell of the human breast in normal development and cancer.Global breast cancer: the lessons to bring home.Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohortThe patient experienceLetrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors.Established breast cancer risk factors by clinically important tumour characteristics.The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983-1999.Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer.Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort studyBreast cancer incidence, stage, treatment and survival in ethnic groups in South East England.Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control studyGenetic susceptibility loci for breast cancer by estrogen receptor statusCancer treatments.Qualitative age interactions in breast cancer studies: mind the gap.Racial disparities in survival and age-related outcome in postsurgery breast cancer patients in a new york city community hospital.The effect of local therapy on breast cancer mortality: is there an age-interaction?Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up.Qualitative age interactions in breast cancer studies: a mini-review.Basal phenotype breast cancer: implications for treatment and prognosis.Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.Imputing estrogen receptor (ER) status in a population-based cancer registry: a sensitivity analysis.Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women?Breast cancer survival and health iniquities.
P2860
Q21195226-744001F7-C944-4278-AC2D-75A31C003634Q30437453-A77737E8-FB86-4FC5-87D2-622F88E6A6CDQ33330850-2BC66422-891B-4DDD-B1BA-EDCD6435CE43Q33780746-45DE6841-2AF9-427C-AFCA-980696499FB3Q34106175-523188AF-19EA-4A9D-88A7-5D6102B7AE81Q34142021-BC6F6072-D65A-4D5A-A5B8-416B5154B637Q34267427-54D58165-F98B-4416-A631-6B52EB6E9335Q34479719-DE679A28-0672-4585-B11B-09A66CAD3004Q34639174-5A494EB8-0B67-40ED-9E82-D520D5D849D2Q34814407-6587FF1E-515E-4B83-BF56-AD7E9CB843C2Q35022847-0AC4FFD7-9B0A-4F41-BDCA-4A9DFCC6940EQ35023428-DE109B80-BA3E-4C7C-86A0-CC9535A7BFADQ35119701-D759B9E8-86AE-452F-AE99-2E87836D4C13Q35190796-A6F3A2EB-3E9A-4F83-AE7C-F3359BD4DE38Q35669146-AEA60B0F-D70B-476A-B37C-C08E845855D9Q35684585-029F30E8-8DD2-4EB4-9CBA-63F9B9BEAAFEQ35908991-C18B6807-844A-4841-887B-500389BED9C4Q36004066-686BFEDB-66D1-4EA2-A0E3-BE7002F64424Q36026414-63FDAC19-2857-42DB-8E75-11FF11F29FB8Q36026418-DB572495-6975-4F85-A176-CBE8D90C7DC9Q36124755-2B366E0A-DC0E-4E6A-A3ED-0A7CDA693CE0Q36611606-7BCBD89D-5B0A-402D-824C-0935CF89BDFEQ36612312-1D663636-FA19-4F41-B3D9-28D0CAB87485Q36935007-96E91393-E0AC-4567-B3F0-E723208754E7Q37038646-B4C12114-6526-42A3-B8D1-C9789137189FQ37135283-A304B72E-11DB-4A29-9FE5-A2C132F1573AQ37150630-BF47A0BD-6AD1-4DD2-8794-641EE6208CD7Q37156413-712EFB1D-6A97-4FA9-967C-5F1C8512239FQ37299531-C56EAFC2-520E-4030-8B2F-C600F6F5EA61Q37411636-CB5F28B5-E312-4614-AE2D-88E58FE0266BQ37622317-FD1D7454-F4E6-49BF-9167-6E19AFCCE19CQ37660353-8C732872-91DD-42EA-861D-2A841FD41970Q37675989-06E7E648-3909-46D5-9F6C-CCCA9C58CDF2Q37818228-851F2320-B804-4EAA-94A1-740F3136DBEBQ37853555-4EDC67F0-B9E9-436E-B0D8-98824F24E044Q38933874-93BA0547-8047-4D36-8E01-159BEA922BABQ39112367-BBDAE0EC-0F89-415B-B8BE-6A549BD7FE7EQ39127680-FE1EF22C-AB49-4BB9-B9AC-0376AE73DCAAQ39564960-A35185FD-E49D-43A0-A2BC-554EA59908AAQ40534321-11EF6462-B9C4-4243-B886-E43C48F24B46
P2860
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Distinct breast cancer inciden ...... between etiology and outcome.
@en
Distinct breast cancer inciden ...... between etiology and outcome.
@nl
type
label
Distinct breast cancer inciden ...... between etiology and outcome.
@en
Distinct breast cancer inciden ...... between etiology and outcome.
@nl
prefLabel
Distinct breast cancer inciden ...... between etiology and outcome.
@en
Distinct breast cancer inciden ...... between etiology and outcome.
@nl
P1476
Distinct breast cancer inciden ...... between etiology and outcome.
@en
P2093
Ismail Jatoi
William F Anderson
P2888
P304
P356
10.1007/S10549-004-3777-3
P407
P577
2005-03-01T00:00:00Z